A Clinical Study in Patients With Chronic Idiopathic Thrombocytopenic Purpura in R788
Status:
Active, not recruiting
Trial end date:
2023-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate the efficacy, safety and pharmacokinetics of R788
compared with placebo, and to investigate the safety and efficacy of long term dosing of R788
in patients with chronic idiopathic thrombocytopenic purpura.